Biotech Breakthroughs

Results

55

7 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

55 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$524.37	-2.0%	38.2%	US$12.1b	US$678.06	9.4	63.7%	n/a	Pharmaceuticals & Biotech
	INSM	US$130.66	-1.2%	0.9%	US$28.1b	US$200.05	25.1	67.0%	n/a	Pharmaceuticals & Biotech
	ARDX	US$3.92	-0.5%	-33.1%	US$1.0b	US$13.00	2.2	61.5%	n/a	Pharmaceuticals & Biotech
	PRAX	US$369.84	-0.2%	725.6%	US$10.5b	US$633.16	7.7	71.7%	n/a	Pharmaceuticals & Biotech
	ANAB	US$58.99	1.9%	198.1%	US$1.8b	US$87.09	7.5	48.1%	38.2%	Pharmaceuticals & Biotech
	MRKR	US$1.29	11.2%	11.2%	US$19.2m	US$7.87	8.0	73.4%	n/a	Pharmaceuticals & Biotech
	ZYME	US$26.07	7.2%	84.9%	US$1.8b	US$40.33	49.8	39.6%	n/a	Pharmaceuticals & Biotech
	IONS	US$59.62	5.5%	39.3%	US$9.9b	US$88.00	11.3	68.0%	n/a	Pharmaceuticals & Biotech
	CLRB New	US$2.59	-0.4%	-41.3%	US$20.6m	US$11.50	0.7	56.0%	n/a	Pharmaceuticals & Biotech
	RVMD	US$216.00	5.1%	491.1%	US$45.4b	US$221.90	17.8	60.0%	n/a	Pharmaceuticals & Biotech
	CAPR	US$7.08	69.0%	-1.3%	US$412.2m	US$10.50	1.7	62.7%	n/a	Pharmaceuticals & Biotech
	RNXT	US$1.32	17.4%	51.1%	US$52.8m	US$7.00	30.0	77.2%	n/a	Pharmaceuticals & Biotech
	ABEO New	US$6.13	-17.8%	-12.4%	US$352.3m	US$18.86	13.7	70.2%	n/a	Pharmaceuticals & Biotech
	INMB	US$2.23	9.3%	-5.5%	US$58.6m	US$7.00	3.0	43.4%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.71	-6.6%	-42.5%	US$156.6m	US$3.20	119.7	67.8%	n/a	Pharmaceuticals & Biotech
	LCTX	US$1.10	0%	-7.6%	US$268.1m	US$5.50	21.3	74.5%	n/a	Pharmaceuticals & Biotech
	ALDX	US$1.58	3.9%	-71.9%	US$93.5m	US$6.60	2.5	55.2%	n/a	Pharmaceuticals & Biotech
	ACIU New	US$2.57	1.2%	25.4%	US$251.6m	US$8.59	11.9	45.3%	n/a	Pharmaceuticals & Biotech
	LGVN	US$0.82	10.1%	2.8%	US$25.1m	US$7.15	22.1	60.1%	n/a	Pharmaceuticals & Biotech
	CGON	US$80.68	4.8%	216.0%	US$6.8b	US$91.08	1148.3	63.0%	n/a	Pharmaceuticals & Biotech
	VRDN	US$24.80	8.4%	36.7%	US$2.7b	US$36.63	39.5	63.0%	n/a	Pharmaceuticals & Biotech
	MNOV	US$1.34	1.5%	3.1%	US$65.0m	US$9.00	71.7	71.2%	n/a	Pharmaceuticals & Biotech
	VERA	US$32.28	6.6%	46.3%	US$2.3b	US$77.14	5.7	65.8%	n/a	Pharmaceuticals & Biotech
	LRMR	US$4.06	-5.8%	11.2%	US$450.9m	US$14.30	3.3	51.7%	n/a	Pharmaceuticals & Biotech

Page 1 of 2